To more accurately reflect the mission and vision of the program, Fox Chase Cancer Center recently announced that the name of the Pain and Palliative Care Program has been changed to the Supportive Oncology and Palliative Care Program.
FDA has initiated the approval of leucovorin calcium tablets, rushing them to market as part of a push from the Trump administration to identify potential treatments for autism spectrum disorder.
